Hard-Shell Chamber

Reviewed by: HBOT Hub Research Desk  ·  Last updated: October 2026

Overview

Hard-shell chambers are rigid-construction units (typically steel, aluminum, or thick acrylic) that can safely reach the 2.0–3.0 ATA pressures recognised by the Undersea and Hyperbaric Medical Society (UHMS) for medical HBOT indications. All FDA-cleared medical HBOT devices are hard-shell.

"Hard-shell" is a construction category rather than a specific chamber type. Both monoplace and multiplace clinical chambers are hard-shell. The term is primarily used in contrast with soft-shell portable chambers (which operate only at 1.3 ATA), which is why hard-shell appears in home-market comparisons more than clinical references.

Hard-shell chambers are engineered to pressure vessel standards (ASME PVHO-1 in the US, EN 14931 in Europe) and are rated for sustained operation at 3.0 ATA or deeper. Materials are typically steel-and-acrylic composite (clear monoplace chambers) or steel plate (multiplace vessels). Testing includes hydrostatic pressure certification well above operating pressure, cyclic fatigue testing, and periodic recertification throughout the device lifespan.

How It Works

The rigid shell maintains structural integrity at depth. Hard-shell chambers can be pressurised with pure oxygen (monoplace configuration) or air plus BIBS oxygen delivery (multiplace configuration). The construction allows electrical penetrations for lighting, intercom, patient monitoring, and medical equipment — subject to hyperbaric safety certification per NFPA 99. Chamber integrity at 3.0 ATA requires the shell to withstand a pressure differential of nearly 30 psi.

Specifications

Clinical Uses

• All 14 UHMS-approved indications — the clinical standard for medical HBOT.
• Emergency HBOT at 2.8–3.0 ATA (CO poisoning, DCS, gas gangrene).
• Wound care at 2.4 ATA (CMS reimbursement standard).
• Neurological research at 2.0 ATA (Efrati Lab protocols).
• Veterinary clinical HBOT.
• Dive training and commercial dive medicine.

Patient Experience

Patient experience depends on whether the hard-shell is a monoplace (lie-down transparent cylinder) or multiplace (sit-up room-like environment). The chamber material itself is not sensed by the patient during treatment; only the pressure change and oxygen breathing differ from an unpressurised environment.

Pros & Cons

Advantages

• Only configuration FDA-cleared for medical HBOT.
• Supports treatment at UHMS-standard pressures (2.0–3.0 ATA).
• Rated for 100% oxygen environment (monoplace) with full fire-safety engineering.
• Durable, long operational lifespan (20+ years with maintenance).

Limitations

• Not portable — fixed installation requires reinforced facility.
• Capital cost substantially higher than soft-shell.
• Operational complexity (NFPA 99, certified staffing).

Cost & Access

Hard-shell clinical chambers range $150K–$300K (monoplace) to $500K–$2M+ (multiplace). Facility costs typically match or exceed chamber costs. Hard-shell is a capital investment appropriate for hospital hyperbaric programmes, UHMS-accredited clinics, and larger wound-care centres — not for home use.

Key References

• ASME PVHO-1 — Safety Standard for Pressure Vessels for Human Occupancy.
• NFPA 99 — Health Care Facilities Code (Chapter 14: Hyperbaric Facilities).
• UHMS Clinical Hyperbaric Facility Accreditation Manual.

Research disclaimer: This reference is for educational purposes only. HBOT is a regulated medical treatment that must be administered under appropriate professional supervision. Always consult a qualified physician before considering hyperbaric therapy. Information reflects published research and regulatory guidance available at the time of review.